Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs.
about
Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retrovirusesAn analysis of vertebrate mRNA sequences: intimations of translational controlEnvelope glycoprotein and CD4 independence of vpu-facilitated human immunodeficiency virus type 1 capsid exportThe human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: implications for the mechanism of degradationRTE and CTE mRNA export elements synergistically increase expression of unstable, Rev-dependent HIV and SIV mRNAsRemodeling of the Host Cell Plasma Membrane by HIV-1 Nef and Vpu: A Strategy to Ensure Viral Fitness and PersistenceVpu Protein: The Viroporin Encoded by HIV-1Animal virus schemes for translation dominanceThe major form of hepatitis C virus alternate reading frame protein is suppressed by core protein expressionPersistent infection of macaques with simian-human immunodeficiency virusesAn intact TAR element and cytoplasmic localization are necessary for efficient packaging of human immunodeficiency virus type 1 genomic RNA.Selection and characterization of human immunodeficiency virus type 1 mutants that are resistant to inhibition by the transdominant negative RevM10 proteinA Naturally Occurring rev1-vpu Fusion Gene Does Not Confer a Fitness Advantage to HIV-1.Modulation of HIV-1-host interaction: role of the Vpu accessory proteinPresence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1Human immunodeficiency virus env expression becomes Rev-independent if the env region is not defined as an intronA structured retroviral RNA element that mediates nucleocytoplasmic export of intron-containing RNAA small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent.CAML does not modulate tetherin-mediated restriction of HIV-1 particle releaseAntagonism of tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartmentRegulation of virus release by the macrophage-tropic human immunodeficiency virus type 1 AD8 isolate is redundant and can be controlled by either Vpu or Env.Serine- and arginine-rich proteins 55 and 75 (SRp55 and SRp75) induce production of HIV-1 vpr mRNA by inhibiting the 5'-splice site of exon 3A rev1-vpu polymorphism unique to HIV-1 subtype A and C strains impairs envelope glycoprotein expression from rev-vpu-env cassettes and reduces virion infectivity in pseudotyping assays.Production of avian leukosis virus particles in mammalian cells can be mediated by the interaction of the human immunodeficiency virus protein Rev and the Rev-responsive element.GPG-NH2 acts via the metabolite alphaHGA to target HIV-1 Env to the ER-associated protein degradation pathway.The human immunodeficiency virus type 1 gag gene encodes an internal ribosome entry site.Translational control of viral gene expression in eukaryotesSpecificity of RSG-1.2 peptide binding to RRE-IIB RNA element of HIV-1 over Rev peptide is mainly enthalpic in origin.Efficiency of reinitiation of translation on human immunodeficiency virus type 1 mRNAs is determined by the length of the upstream open reading frame and by intercistronic distance.Mutational definition of the human immunodeficiency virus type 1 Rev activation domain.Decreased human immunodeficiency virus type 1 plasma viremia during antiretroviral therapy reflects downregulation of viral replication in lymphoid tissueRobust growth of human immunodeficiency virus type 1 (HIV-1)Selectively reduced tat mRNA heralds the decline in productive human immunodeficiency virus type 1 infection in monocyte-derived macrophages.The sequence complementarity between HIV-1 5' splice site SD4 and U1 snRNA determines the steady-state level of an unstable env pre-mRNA.Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle productionSplicing efficiency of human immunodeficiency virus type 1 tat RNA is determined by both a suboptimal 3' splice site and a 10 nucleotide exon splicing silencer element located within tat exon 2.Evidence that Vpu modulates HIV-1 Gag-envelope interaction towards envelope incorporation and infectivity in a cell type dependent manner.Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapiesHIV-1 replication and the cellular eukaryotic translation apparatusConverging strategies in expression of human complex retroviruses
P2860
Q24561846-5D3E470D-69E1-4C89-AF57-75648F9EB4DCQ24642530-ACF5F6C2-5936-4567-9DDA-6F9089EF01CBQ24644301-D09674A6-8C04-41E4-9244-B47EF3CE5E32Q24676509-D078A0AA-E38A-4E6A-A59E-13FBB7A28871Q25256626-8AB45FEB-9FFB-43E7-895D-0E5053BE2630Q26767362-690F513D-2E42-4CD4-92A7-61C27B06B189Q26801489-93B388B2-3087-4449-A933-19757A171B80Q26851527-862DD0DA-E95A-4CB0-963B-D92DD9589C48Q27486151-058ACB90-1AA7-4471-ABB1-8938F25C83ADQ28775731-F34F7B78-44B1-4189-937C-9CABE496D5BBQ30303886-3D97B085-3A53-46C1-9D87-A922DE929FD5Q30304057-9EE623BE-EC2B-457F-B745-0FBB7FFD71F7Q30381208-17489B4D-6103-41A4-9BB4-05DFF6696A7EQ30397761-5991CC5B-7829-48C8-BC8B-8B7C8E79114BQ30450216-59C1CC07-AE20-49F3-979F-0EFB9239C988Q30452134-14422B94-33FD-4D41-94D1-B0DCB79E920AQ30452691-AFE63F3C-EA9B-47A8-8B73-389E39EEF633Q30454030-BA3D134F-E376-4A36-B6A5-DC40E96560A6Q33528976-A720357E-9572-43CE-A535-7AE1ADFCB252Q33553369-7475FC46-8814-4262-BD51-EE1A2ECA573BQ33640055-BA26E9B2-ECC3-4F08-A5D4-B89DE1B915BDQ33649436-CC065454-A7F9-4A2E-B716-B4D16C0D4F43Q33653774-3AF83257-438B-4993-AB58-EA0C0107FCC5Q33735159-2E0A95BB-BA4F-4F9B-A3F5-709B91D26051Q33758760-A94D7997-1112-4389-B83F-3A847EE0AFE3Q33834664-11CD2DEF-0B36-4A53-B8E6-539A7C8C4BB5Q33935121-361274A1-C46C-404B-86FA-0222C02F9DEAQ33997066-9153E9BA-EE96-4F34-A9F5-1756CB2F452CQ34058977-022C7F98-FBAF-4965-AA79-7D3314AF4B0BQ34132236-8C58736D-4332-47F4-A48D-E0D2E6AB149CQ34176667-AB2AF568-229F-43F7-AD13-2E064F78314CQ34351276-A93C49BA-2CBF-43E3-9FE1-8A6B8BEEE4DCQ34351941-EE943B6C-AADC-460A-A35E-EBF7597C04A4Q34363471-07E94265-1EEB-432C-B96C-B2FEBFE0516CQ34391721-1562684F-F2D7-4DC9-BBFC-A5EA3B411666Q34626299-89614CB4-D002-4277-AFD6-7D0F9E52735EQ34684340-68547416-010E-46BA-B0E9-99CDAC36D489Q34797004-A81036BD-6276-401A-A9B5-AC2C86B45A53Q35014929-3D7EA2E9-6F5C-4723-8706-90757C76837DQ35261679-BB2D0305-A779-4004-AE22-BF0C9257C019
P2860
Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Env and Vpu proteins of human ...... om multiple bicistronic mRNAs.
@ast
Env and Vpu proteins of human ...... om multiple bicistronic mRNAs.
@en
type
label
Env and Vpu proteins of human ...... om multiple bicistronic mRNAs.
@ast
Env and Vpu proteins of human ...... om multiple bicistronic mRNAs.
@en
prefLabel
Env and Vpu proteins of human ...... om multiple bicistronic mRNAs.
@ast
Env and Vpu proteins of human ...... om multiple bicistronic mRNAs.
@en
P2093
P2860
P1433
P1476
Env and Vpu proteins of human ...... om multiple bicistronic mRNAs.
@en
P2093
B K Felber
G N Pavlakis
S Schwartz
P2860
P304
P407
P577
1990-11-01T00:00:00Z